Over time, small frown lines begin to form between the eyebrows. Many people just assume this is a natural part of the aging process and leave it untreated, but there is a simple solution that is available – Dysport and Xeomin.
What is Dysport?
Dysport is an injectable solution, made by Galderma, that will help treat or improve the appearance of moderate to severe frown lines that have formed between the eyebrows. It is very similar to other cosmetic procedures, such as Botox, but it does not have the potential to temporarily hinder facial movements or change the overall appearance of the face.
Dysport is available by prescription only and must be administered by a trained healthcare provider, like Dr. Vivian Bucay and her staff. Dr. Vivian Bucay and her team can help you determine if Dysport is right for you.
What is Xeomin?
Xeomin is a prescription injection, made by MERZ, that is used to help temporarily improve facial aesthetics. This prescription injection is a solution that contains botulinum toxin type A. It specifically targets moderate to severe frown lines that have appeared between the eyebrows. San Antonio Dermatologist, Dr. Vivian Bucay and her team at Bucay Center for Dermatology and Aesthetics can help you explore whether or not Xeomin is the right solution for your current needs.
Who is a Good Candidate for Dysport & Xeomin?
Dysport and Xeomin are intended for use by men and women under the age of 65 who have moderate to severe frown lines that formed between the eyebrows. People wishing to dramatically reduce the appearance of these fine lines and wrinkles in as little as one office visit are good candidates for this type of procedure.
Who Should Not Consider Using Dysport or Xeomin?
Dysport or Xeomin should not be used by anyone who has an allergy to any of the ingredients in the injection. People with allergies to cow’s milk protein or any botulinum toxin should not use either injection. Our staff will ask you a series of health-related questions and perform a brief visual inspection of your skin. This will help us determine if Dysport or Xeomin is the treatment of choice to help you.
Some facial conditions and/or recent cosmetic procedures may prevent you from being a good candidate for the use of Dysport or Xeomin. For example, people with sagging eyelid folds, deep facial scars, oily skin, and weak facial muscles may have difficulty seeing results from the injections and therefore should consider using another form of treatment.
What to Expect During Treatment
When you schedule an appointment for Dysport or Xeomin at Bucay Center for Dermatology and Aesthetics, you can expect to spend approximately 30 minutes with us. The actual treatment takes approximately 10-20 minutes. We will put a single injection into five different points in the area over your eyebrows.
What to Expect After Dysport or Xeomin Treatment
After treatment has been administered, we will provide you with a cold pack or cold compress. You will need to hold the compress over the injection site for several minutes. This prevents the area from swelling after treatment and reduces any pain or discomfort.
How Long Do Dysport and Xeomin Injections Last?
Xeomin and Dysport are both temporary and last for a short period of time. Results from the injection are noticeable after the first appointment and will last up to four months. We encourage our patients to schedule another treatment after 2 to 4 months to keep the frown lines from reappearing.
Dysport Before and After
Schedule a Consultation
We recommend credentialing your injector. Dr. Bucay is a Board Certified Dermatologist and recognized as an Expert Injector. ExpertInjectors™ are properly qualified to perform injectable procedures and only administer products that are FDA-approved for aesthetic use. Dr. Vivian Bucay is qualified to administer Dysport and Xeomin to our patients. Schedule an appointment today to discuss either of these injections are right for you. Call (210) 692-3000 in La Casita and (210) 370-9995 in Sonterra today! Dr. Bucay serves San Antonio, TX and surrounding areas.